CHANGE IN RATINGS
initiated at UBS. Rated a Buy with a $31 price target. Initiated 2007 EPS estimates of $1.06.
Bank of America
upgraded at UBS. Rating raised to Buy from Neutral. Price target raised to $59 from $57. Reiterates 2007 EPS estimates of $4.70.
( BEAS) downgraded at UBS. Rating changed to Neutral from Buy. Price target increased to $14 from $13.50. Reiterates 2007 EPS estimates of $0.40.
Morgan Stanley upgrades
from equalweight to overweight and moves price target from $27 to $30.
downgraded at Merrill from Buy to Neutral. Management does not seem willing to materially boost the dividend in the near term. Estimates also cut, to reflect lower expected advertising revenue.
upgraded at UBS. Rating changed to Neutral from Reduce. Price target reduced to $32 from $35. 2007 EPS estimates reduced to $4.61 from $5.45.
downgraded from Outperform to Market Perform at Piper Jaffray. $42 price target. Company guided to lower sequential growth, based on weakness in Europe and the domestic consumer sector.
( OMTR) initiated at Jefferies. Introduces Neutral rating, price target of $22 and 2007 EPS estimates of $0.09.
upgraded at Citigroup from Hold to Buy. $68 price target. Sale of the trading business and rising value of the company's California assets should push the stock higher.
upgraded at Goldman Sachs to Buy from Neutral based on improvements or divestitures of poor-performing assets and turnaround in Bell division. See company benefiting from higher multiples of commercial aerospace group, which makes up 72% of EBIT. Price target raised to $127 from $107.
downgraded at Morgan Stanley from overweight to equalweight and lowers price target from $109 to $106.
STOCK COMMENTS / EPS CHANGES
price target raised at UBS. Price target raised to $49 from $45. Reiterates 2007 EPS estimates of $1.90 and Buy rating.
estimates lowered at Jefferies. 2007 EPS estimates lowered to $2.33 from $2.35. Reiterates Buy rating and $50 price target.
estimates lowered at UBS. 2007 EPS estimates lowered to $6.64 from $6.76. Reiterates Buy rating and $137 price target.
numbers raised at UBS. Price target increased to $63 from $58. 2007 EPS estimates raised to $1.77 from $1.75. Reiterates Buy rating.
( SIRF) numbers lowered at UBS. Price target lowered to $31 from $33. 2007 EPS estimates lowered to $0.47 from $0.54. Reiterates Buy rating.
numbers raised at UBS. Price target raised to $44 from $39. 2007 EPS estimates raised to $2.35 from $2.33. Reiterates Neutral rating.
numbers lowered at Jefferies. 2007 EPS estimates decreased to $0.51 from $0.54. Price target lowered to $34 from $36. Reiterates Buy rating.
2007 estimates cut at Goldman to $0.86 from $0.91 after company lowered revenue expectations and announced Jerry Yang as CEO. See unfavorable risk/reward as company has major transitions ahead. Maintained Neutral rating and $32 target.